Abstract
Pre-clinical animal models are important to study the fundamental biological and functional mechanisms involved in the longitudinal evolution of heart failure (HF). Particularly, large animal models, like nonhuman primates (NHPs), that possess greater physiological, biochemical, and phylogenetic similarity to humans are gaining interest. To assess the translatability of these models into human diseases, imaging biomarkers play a significant role in non-invasive phenotyping, prediction of downstream remodeling, and evaluation of novel experimental therapeutics. This paper sheds insight into NHP cardiac function through the quantification of magnetic resonance (MR) imaging biomarkers that comprehensively characterize the spatiotemporal dynamics of left ventricular (LV) systolic pumping and LV diastolic relaxation. MR tagging and phase contrast (PC) imaging were used to quantify NHP cardiac strain and flow. Temporal inter-relationships between rotational mechanics, myocardial strain and LV chamber flow are presented, and functional biomarkers are evaluated through test-retest repeatability and inter subject variability analyses. The temporal trends observed in strain and flow was similar to published data in humans. Our results indicate a dominant dimension based pumping during early systole, followed by a torsion dominant pumping action during late systole. Early diastole is characterized by close to 65% of untwist, the remainder of which likely contributes to efficient filling during atrial kick. Our data reveal that moderate to good intra-subject repeatability was observed for peak strain, strain-rates, E/circumferential strain-rate (CSR) ratio, E/longitudinal strain-rate (LSR) ratio, and deceleration time. The inter-subject variability was high for strain dyssynchrony, diastolic strain-rates, peak torsion and peak untwist rate. We have successfully characterized cardiac function in NHPs using MR imaging. Peak strain, average systolic strain-rate, diastolic E/CSR and E/LSR ratios, and deceleration time were identified as robust biomarkers that could potentially be applied to future pre-clinical drug studies.
Highlights
The complicated multifaceted pathogenesis of heart failure (HF) is still not fully understood
Over the past few decades, the rodent-to-man translational approach has shed insight into some fundamental biological and molecular mechanisms involved in HF and led to the recognition of specific molecular signaling pathways involved during the longitudinal cardiac remodeling process that results in HF [1]
Landmark studies in surgical canine models have provided a deeper understanding of the spatial progression of myocardial ischemia, the time-course leading to eventual cell death and infarct expansion, and the discovery of achieving myocardial salvage through timely thrombolytic therapy [13,14]
Summary
The complicated multifaceted pathogenesis of heart failure (HF) is still not fully understood. Despite the advances gained from small animal studies, there exist significant differences between rodents and humans in cardiac characteristics such as heart rate, oxygen consumption, perfusion, metabolism, contractile protein expression, stem cell phenotypes and responses to protein alteration [11,12]. Studies conducted in large animal models have evaluated the upward translation of pharmacological [18,19,20], stem cell [21,22] or genetic therapy [23,24], previously tested in the rodent space, setting up the stage for future clinical translation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.